Study With Gefitinib in Combination With Olaparib (AZD2281) Versus Gefitinib Alone
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Olaparib
Related studies linked through entity extraction aliases.
Phase I Study of Olaparib With Cisplatin Based Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE1
Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
- Status
- UNKNOWN
- Phase
- PHASE1
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Cediranib Maleate and Olaparib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Peritoneal Cancer or Recurrent Triple-Negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Study to Compare the Efficacy and Safety of Olaparib When Given in Combination With Carboplatin and Paclitaxel, Compared With Carboplatin and Paclitaxel in Patients With Advanced Ovarian Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Open Label Study to Assess Efficacy and Safety of Olaparib in Confirmed Genetic BRCA1 or BRCA2 Mutation Pats
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status
- Status
- COMPLETED
- Phase
- PHASE2
AZD2281 and Irinotecan in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Study to Assess The Efficacy and Safety of a PARP Inhibitor For The Treatment of BRCA-positive Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2